SCHEMBL6874485

SCHEMBL6874485

CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)Nc3ccc(Oc4ccccc4)cc3)CC2)nc2c1CCCC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.54
EPHX2 P34913 2/20 0.47
CXCR3 P49682 1/20 0.46
MCHR1 Q99705 10/20 0.44
ADRA2A P08913 9/20 0.44
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
XBP1 P17861 1/20 0.41
CYP2C19 P33261 1/20 0.41
STAT3 P40763 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6874492 1.00 EPHX1 (0.54) EPHX1EPHX2CXCR3MCHR1ADRA2A
SCHEMBL6868351 0.92 USP30 (0.46) EPHX1MCHR1ADRA2ANPC1RAB9A
SCHEMBL6868346 0.92 USP30 (0.46) EPHX1MCHR1ADRA2ANPC1RAB9A
SCHEMBL6874499 0.90 MCHR1 (0.44) EPHX1EPHX2MCHR1ADRA2ASMN1; SMN2
SCHEMBL6874504 0.90 MCHR1 (0.44) EPHX1EPHX2MCHR1ADRA2ASMN1; SMN2
SCHEMBL6874878 0.90 NPC1 (0.54) EPHX1EPHX2MCHR1ADRA2ASMN1; SMN2
SCHEMBL6874872 0.90 NPC1 (0.54) EPHX1EPHX2MCHR1ADRA2ASMN1; SMN2
SCHEMBL6876262 0.89 SMN1; SMN2 (0.55) EPHX1MCHR1ADRA2ASMN1; SMN2TP53
SCHEMBL6877480 0.89 NOX1 (0.48) EPHX1EPHX2MCHR1ADRA2ASMN1; SMN2
SCHEMBL6877475 0.89 NOX1 (0.48) EPHX1EPHX2MCHR1ADRA2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed